Denali Therapeutics, Inc. (DNLI)
20.77
+1.23
(+6.29%)
USD |
NASDAQ |
Jun 09, 16:00
20.77
0.00 (0.00%)
After-Hours: 17:11
Denali Therapeutics Total Assets (Quarterly) : 1.266B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 3.179B |
| ImmunityBio, Inc. | 646.64M |
| Summit Therapeutics, Inc. | 647.86M |
| Arrowhead Pharmaceuticals, Inc. | 2.268B |
| Biogen, Inc. | 29.48B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 339.92M |
| Shareholders Equity (Quarterly) | 926.10M |
| Debt to Equity Ratio | 0.0432 |
| Current Ratio | 9.285 |
| Net Debt Paydown Yield | 0.09% |